Alec J Kacew

Alec J Kacew

University of Chicago - Chicago / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4891152
person_outline Alec J Kacew's MOST POPULAR ARTICLES
1-) FGFR3 Alterations in the Era of Immunotherapy for Urothelial Bladder CancerA Kacew, RF SweisFrontiers in Immunology 11, 575258, 2020572020
2-) A phase II study of nivolumab (N) plus ipilimumab (I) in radioidine refractory differentiated thyroid cancer (RAIR DTC) with exploratory cohorts in anaplastic (ATC) and …JH Lorch, JA Barletta, M Nehs, R Uppaluri, EK Alexander, RI Haddad, ...Journal of Clinical Oncology 38 (15_suppl), 6513-6513, 2020542020
3-) COVIDOSE: a phase II clinical trial of low‐dose tocilizumab in the treatment of noncritical COVID‐19 pneumoniaGW Strohbehn, BL Heiss, SJ Rouhani, JA Trujillo, J Yu, AJ Kacew, ...Clinical Pharmacology & Therapeutics 109 (3), 688-696, 2021532021
4-) The development of STING agonists and emerging results as a cancer immunotherapyJB Hines, AJ Kacew, RF SweisCurrent oncology reports 25 (3), 189-199, 2023482023
5-) Artificial intelligence can cut costs while maintaining accuracy in colorectal cancer genotypingAJ Kacew, GW Strohbehn, L Saulsberry, N Laiteerapong, NA Cipriani, ...Frontiers in Oncology 11, 630953, 2021